Technology News and Research

RSS

New book proposes engineering approach to US health care reform

The current problems of access, affordability and quality in the US healthcare system won't be solved by providing health insurance to all. The editors of the new book Engineering the System of Healthcare Delivery (ISBN: 978-1-60750-532-7) propose an engineering approach to healthcare. In this publication by IOS Press, editors William B. Rouse and Denis A. Cortese and a team of highly regarded thought leaders in the field explain their vision.

3 Jun 2010

Experts call on EU Parliament to ensure widespread benefits of nanomedicine

Experts from key EU projects united in Brussels at Nanomedicine in Europe today to deliver a strong message to the European Parliament that concerted and coordinated action is needed to ensure the widespread benefits offered by advances in nanomedicine are not squandered.

3 Jun 2010

Bangalore INDIA BIO 2010 inaugurated

Bangalore INDIA BIO 2010, India's premier Biotechnology event organized by the Department of Information Technology, Biotechnology and Science & Technology, Government of Karnataka, Vision Group on Biotechnology and MM Activ Sci-Tech Communications Co was inaugurated today by Shri B.S. Yeddyurappa, Hon'ble Chief Minister of Karnataka, and Shri Katta Subramanya Naidu - Hon'ble Minister for IT & BT, Information, Excise and BWSSB, Government of Karnataka.

2 Jun 2010

IntriCon completes divestiture of RTI Electronics

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group.

2 Jun 2010

Celerion announces launch of new Hybrid Phase I/ ECG Core lab

Celerion, the premier provider of innovative early stage clinical research solutions, announces the launch of a new Hybrid Phase I/ ECG Core lab. The Hybrid Phase I/ ECG Core lab provides highly automated ECG analysis for Celerion's global Phase I clinical network. Celerion's highly automated approach employs cutting-edge technology to perform automated measurement of ECG recordings, thereby minimizing cardiologist review and providing clients with faster access to data.

2 Jun 2010

Competitive Technologies to raise over $5M to accelerate sales of Calmare Pain Therapy Treatment

Competitive Technologies, Inc. today announced that it has signed an agreement to raise over $5 million by selling 2 million shares of equity to Crisnic Fund, S.A. based on a 15% discount from the volume weighted average price on the date the SEC declares the registration effective, as detailed in the 8-K being filed today.

2 Jun 2010

Axcan extends use of Medidata Rave as EDC and CDM system

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today announced that Axcan Pharma Inc. has extended its use of Medidata Rave as its electronic data capture and clinical data management system, bringing study build and execution into the organization through Medidata training and mentoring.

2 Jun 2010

Oculus launches Microcyn Negative-Pressure Wound Therapy Solution

Oculus Innovative Sciences, Inc., a commercial medical technology company that designs, produces and markets safe and effective tissue care products based upon the Microcyn® Technology platform, today introduced the Microcyn Negative-Pressure Wound Therapy Solution™ for the U.S. professional healthcare market. Within the pH ranges of 6-7.8 desired for optimum negative-pressure wound therapy, Microcyn is intended for the irrigation and management of wounds via these advanced systems.

2 Jun 2010

Barriers, misinformation still prevent many from seeking flu protection for their families: Canadian Flu Report

According to the Canadian Flu Report released today, 40 per cent of parents are now more interested in vaccinating themselves and their children against seasonal flu following last year's H1N1 outbreak. Yet, significant barriers and misinformation are still preventing many from actually seeking proper flu protection for their families.

2 Jun 2010

Novella Clinical announces acquisition of Prologue

Novella Clinical announced today the acquisition of Prologue Research International, Inc. an Ohio-based full service Clinical Research Organization that focuses exclusively on oncology drug development. "The acquisition of Prologue strengthens our oncology therapeutic franchise and is a strategic addition to our earlier announced deal this year with OSI Pharmaceuticals," says Richard Staub, President and Chief Executive Officer.

2 Jun 2010

Holon announces entree into healthcare information technology vertical

Holon, the new standard for healthcare interoperability, today announced its entree into the healthcare information technology vertical. Signaling our new direction is the Holon Brand. Holon: (Greek: holos, "whole") is something that is simultaneously a whole and a part, a system that is itself a part of a larger system and signifies the blending of proven technologies with actionable intelligence to measurably improve care.

2 Jun 2010

Researchers offer solutions for groundwater contamination crisis

Over 100 million people in rural southern Asia are exposed every day to unsafe levels of arsenic from the well-water they drink. It more than doubles their risks for cancer, causes cardiovascular disease, and inhibits the mental development of children, among other serious effects.

2 Jun 2010

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Chronix Biomedical today announced that it will launch a new disease detection and monitoring service for cancer researchers at the upcoming 2010 ASCO Annual Meeting. The "For Investigational Use Only" laboratory-based testing service uses Chronix's breakthrough approach—the Chronix Apoptotic DNA Blood Test—which analyzes apoptotic DNA from dead and dying cells to identify and track ongoing changes associated with specific cancers and other chronic diseases.

2 Jun 2010

Research findings advance the effort to develop AIDS vaccine

In findings that contribute to efforts to design an AIDS vaccine, a team led by Scripps Research Institute scientists has determined the structure of an immune system antibody molecule that effectively acts against most strains of human immunodeficiency virus, the virus that causes AIDS.

2 Jun 2010

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

An enzyme implicated in osteoporosis, arthritis, atherosclerosis and cancer metastasis -- cathepsin K -- eluded reliable detection in laboratory experiments in the past. Now, a research team at the Georgia Institute of Technology has developed an assay that reliably detects and quantifies mature cathepsin K using a technique called gelatin zymography.

2 Jun 2010

Biomoda, Obio sign MOU to establish CLIA-certified clinical laboratory in Ohio

Cancer diagnostics company Biomoda, Inc. and Obio, a corporation formed to pursue public and private funding for cancer research in Ohio, signed a memorandum of understanding to establish a CLIA-certified Biomoda clinical laboratory in Ohio to support ongoing research and development on Biomoda's porphyrin-based assay for the detection of early-stage cancer.

2 Jun 2010

SOFAR licenses Immersion's TouchSense haptics technology for use in ALF-X telesurgical robot system

Immersion Corporation, the leading developer and licensor of haptics technology, today announced that SOFAR S.p.A., a leading Italian manufacturer of medical devices for minimally invasive surgery, has obtained a license to Immersion's TouchSense haptics technology for use in its ALF-X (Advanced Laparoscopy through Force Reflection) telesurgical robot system.

2 Jun 2010

Park Place International to unveil new website in conjunction with MUSE 2010 conference

Park Place International, a provider of comprehensive professional services for MEDITECH clients, is pleased to unveil its new company website in conjunction with the MUSE 2010 conference. Park Place International has been delivering accredited technology lifecycle services to the MEDITECH community for 20 years.

2 Jun 2010

Ablexis to advance transgenic mouse platform for antibody discovery with $12M Series A financing

Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.

2 Jun 2010

AFFiRiS to explore ProBioGen's HuALN technology for AFFITOME-based vaccination concept

AFFiRiS AG will explore ProBioGen's proprietary Human Artificial Lymph Node Technology (HuALN) as analytical tool for its AFFITOME®-based vaccination concept. Under the contract with ProBioGen, AFFiRiS will evaluate the HuALN technology as a human organoid model to investigate drug-related effects in the context of the human immune system in order to select vaccine candidates best suited to be applied in humans.

2 Jun 2010

Technology News and Research

New book proposes engineering approach to US health care reform

Experts call on EU Parliament to ensure widespread benefits of nanomedicine

Bangalore INDIA BIO 2010 inaugurated

IntriCon completes divestiture of RTI Electronics

Celerion announces launch of new Hybrid Phase I/ ECG Core lab

Competitive Technologies to raise over $5M to accelerate sales of Calmare Pain Therapy Treatment

Axcan extends use of Medidata Rave as EDC and CDM system

Oculus launches Microcyn Negative-Pressure Wound Therapy Solution

Barriers, misinformation still prevent many from seeking flu protection for their families: Canadian Flu Report

Novella Clinical announces acquisition of Prologue

Holon announces entree into healthcare information technology vertical

Researchers offer solutions for groundwater contamination crisis

Chronix Biomedical to launch new disease detection, monitoring service for cancer researchers at 2010 ASCO

Research findings advance the effort to develop AIDS vaccine

Researchers develop new technique to detect cathepsin K in atherosclerosis, cancer metastasis

Biomoda, Obio sign MOU to establish CLIA-certified clinical laboratory in Ohio

SOFAR licenses Immersion's TouchSense haptics technology for use in ALF-X telesurgical robot system

Park Place International to unveil new website in conjunction with MUSE 2010 conference

Ablexis to advance transgenic mouse platform for antibody discovery with $12M Series A financing

AFFiRiS to explore ProBioGen's HuALN technology for AFFITOME-based vaccination concept

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News